ProPhase Labs updates on convertible debt conversions, reverse stock split, and transition to OTC market

ProPhase Labs, Inc.

Over $3.3 million of convertible debt converted from $3.8 million principal, reducing indebtedness and increasing equity; remaining unconverted principal less than $500,000.
Reverse stock split of 1-for-10 effective December 5, 2025, and transition from Nasdaq to OTC market effective January 5, 2026.
Management states recent stock volatility due to short-term technical factors including debt conversions and delisting, not changes in underlying asset value.
Conversion floor price of $0.76 per share (post-split) is above current trading price, reducing potential for further conversion-driven selling pressure.
Company reiterates focus on stabilizing capital structure and advancing operations; no fundamental change in long-term strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.